We engage ethically with all providers, and do so transparently and in compliance with country laws, regulations and trade association obligations.
AbbVie is committed to collaborating with health care professionals (HCPs), health care organizations (HCOs) and patient organizations to improve patient health across the globe.
Our interactions with HCPs, HCOs and patient organizations are guided by openness and transparency to ensure public trust and confidence. AbbVie supports disclosure of these relationships wherever possible to demonstrate the integrity of our relationships with HCPs, HCOs and patient organizations.
The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers (HCPs) and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence. To learn more, view our FAQs.
U.S. Centers for Medicare and Medicaid Services (CMS) Open Payments Website
If you have questions on the data contained in the reports, please email [email protected].
Information exchanged with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and patient organizations leads to newer and better therapies and, most importantly, enhanced care for patients. We believe interactions with healthcare professionals and healthcare organizations are essential to advance patient care, gain insights into unmet medical needs and progress the development of new medicines. Our interactions with HCPs and HCOs are based on trust, transparency and integrity, with a goal of providing the public with greater visibility into these interactions to ensure public trust and confidence. AbbVie engages in a range of activities from clinical research to sponsorships to educational activities to exchange information on how new medicines fit into the patient pathway. By bringing greater transparency to these relationships, AbbVie demonstrates its ongoing commitment to strengthening the basis for future collaboration.
AbbVie is committed to making a remarkable impact on patients’ lives and their caregivers. We combine advanced science with a deep knowledge of the patient experience and healthcare systems to help people live better, more productive lives. We pursue learning about patient experiences to understand the issues, concerns and priorities of people affected by disease.
Patient organizations are a source of valuable information and support for patients and their caregivers. We foster patient organization relationships based on mutual trust, respect and goals that reflect AbbVie’s transparent and ethical behavioral standards. Through these relationships, AbbVie contributes to informing patients and caregivers about disease states, treatment options and how to improve quality of life. These partnerships facilitate dialogue between interested parties and help create new, cost-effective health care delivery models.
Annually, AbbVie publishes the financial support provided to European Patient Organizations. Our publication of the following country reports demonstrates our commitment to transparent disclosure of our financial relationships with patient organizations.
Austria
Disclosure Report
Belgium
Disclosure Data
Bosnia and Herzegovina
2022 - Disclosure Report
2023 - No Transfers of Value
Bulgaria
Disclosure Report
Croatia
2022 - Disclosure Report
2023 - Disclosure Report
Czechia
Disclosure Report
Denmark
Disclosure Data
Estonia
2022 - Disclosure Report
2023 - Disclosure Report
Finland
Disclosure Report
France
Disclosure Data
Germany
Disclosure Report
Greece
Disclosure Report
Hungary
2022 - Disclosure Report
2023 - Disclosure Report
Ireland
Disclosure Report
Italy
Disclosure Report
Latvia
2022 - Disclosure Report
2023 - Disclosure Report
Lithuania
2022 - Disclosure Report
2023 - Disclosure Report
Netherlands
Disclosure Data
Norway
Disclosure Report
Poland
Disclosure Report
Portugal
Disclosure Data
Romania
Disclosure Data
Russia
Disclosure Report
Slovakia
Disclosure Report
Slovenia
2022 - Disclosure Report
2023 - Disclosure Report
Spain
Disclosure Report
Sweden
Disclosure Data
Switzerland
Disclosure Report (English, German, French)
Turkey
Disclosure Report
Ukraine
Disclosure Data
United Kingdom
Disclosure Report
AbbVie has a long-standing commitment to supporting programs aimed at increasing the understanding of scientific, clinical and health care issues that improve patient care. In the interest of transparency, we are disclosing the following list of professional conferences sponsored by AbbVie.
Sponsored Professional Conferences 2013
Sponsored Professional Conferences 2014
Sponsored Professional Conferences 2015
Sponsored Professional Conferences 2016
Sponsored Professional Conferences 2017
Sponsored Professional Conferences 2018
Sponsored Professional Conferences 2019
Sponsored Professional Conferences 2020
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?